AstraZeneca PLC Credit Rating

Resultados 1 - 50 de 128

Página de 3 Next

Filtrar por:

Fecha	Tipo de Reporte	Título	Fuente
27 Mar 2024	Peer Snapshot	AstraZeneca PLC - December 2023 (LTM): Peer Snapshot	Moody's Investors Service
26 Mar 2024	Credit Opinion	AstraZeneca PLC: Update to credit opinion	Moody's Investors Service
22 Mar 2024	Issuer Comment	AstraZeneca PLC: AstraZeneca strengthens its oncology portfolio with acquisition of Fusion, a credit positive	Moody's Investors Service
13 Mar 2024	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of AstraZeneca PLC	Moody's Investors Service
22 Dec 2023	Peer Snapshot	AstraZeneca PLC - September 2023 (LTM): Peer Snapshot	Moody's Investors Service
14 Dec 2023	Announcement of Periodic Review	Moody's announces completion of a periodic review for a group of Pharmaceutical issuers	Moody's Investors Service
31 Aug 2023	Peer Snapshot	AstraZeneca PLC - June 2023 (LTM): Peer Snapshot	Moody's Investors Service
15 Aug 2023	Credit Opinion	AstraZeneca PLC: Update following upgrade to A2	Moody's Investors Service
10 Aug 2023	Rating Action	Moody's upgrades AstraZeneca to A2; outlook stable	Moody's Investors Service
13 Jun 2023	Peer Snapshot	AstraZeneca PLC - March 2023 (LTM): Peer Snapshot	Moody's Investors Service
30 May 2023	Credit Opinion	AstraZeneca PLC: Update to credit opinion	Moody's Investors Service
03 Apr 2023	Peer Snapshot	AstraZeneca PLC - December 2022 (LTM): Peer Snapshot	Moody's Investors Service
27 Mar 2023	Announcement of Periodic Review	Moody's announces completion of a periodic review for a group of Pharmaceutical issuers	Moody's Investors Service
16 Dec 2022	Peer Snapshot	AstraZeneca PLC - September 2022 (LTM): Peer Snapshot	Moody's Investors Service
21 Nov 2022	Credit Opinion	AstraZeneca PLC: Update following change of outlook to stable from negative	Moody's Investors Service
16 Nov 2022	Rating Action	Moody's changes outlook on AstraZeneca to stable from negative; affirms A3/P-2 ratings	Moody's Investors Service
26 Sep 2022	Peer Snapshot	AstraZeneca PLC - June 2022 (LTM): Peer Snapshot	Moody's Investors Service
15 Jun 2022	Peer Snapshot	AstraZeneca PLC - March 2022 (LTM): Peer Snapshot	Moody's Investors Service
01 Jun 2022	Credit Opinion	AstraZeneca PLC: Credit ratios improving despite cash flow lagging EBITDA momentum	Moody's Investors Service
19 Apr 2022	Announcement of Periodic Review	Moody's announces completion of a periodic review for a group of Pharmaceutical issuers	Moody's Investors Service
15 Apr 2022	Peer Snapshot	AstraZeneca PLC - December 2021 (LTM): Peer Snapshot	Moody's Investors Service
13 Dec 2021	Peer Snapshot	AstraZeneca PLC - September 2021 (LTM): Peer Snapshot	Moody's Investors Service
30 Nov 2021	Credit Opinion	AstraZeneca PLC: Deleveraging more challenging given lack of earnings growth in 2021	Moody's Investors Service
08 Sep 2021	Peer Snapshot	AstraZeneca PLC - June 2021 (LTM): Peer Snapshot	Moody's Investors Service
02 Aug 2021	Issuer Comment	AstraZeneca PLC: No improvement in credit metrics in 2021 yet but deleveraging opportunity remains following Alexion acquisition	Moody's Investors Service
04 Jun 2021	Peer Snapshot	AstraZeneca PLC - March 2021 (LTM): Peer Snapshot	Moody's Investors Service
25 May 2021	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of AstraZeneca PLC	Moody's Investors Service
13 May 2021	Credit Opinion	AstraZeneca PLC: Update to credit analysis following first quarter results	Moody's Investors Service
25 Mar 2021	Peer Snapshot	AstraZeneca PLC - December 2020 (LTM): Peer Snapshot	Moody's Investors Service
21 Dec 2020	Credit Opinion	AstraZeneca PLC: Update to credit analysis following outlook change to negative	Moody's Investors Service
15 Dec 2020	Rating Action	Moody's affirms AstraZeneca's A3 ratings; changes outlook to negative from stable	Moody's Investors Service
04 Dec 2020	Peer Snapshot	AstraZeneca PLC - September 2020 (LTM): Peer Snapshot	Moody's Investors Service
23 Nov 2020	Issuer Comment	AstraZeneca PLC: COVID-19 vaccine safety and efficacy data brings positive social implications but likely limited EBITDA potential	Moody's Investors Service
18 Nov 2020	Credit Opinion	AstraZeneca PLC: Update to credit analysis - deleveraging momentum remains strong, from a high base	Moody's Investors Service
04 Sep 2020	Peer Snapshot	AstraZeneca PLC - June 2020 (LTM): Peer Snapshot	Moody's Investors Service
07 Aug 2020	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of AstraZeneca PLC	Moody's Investors Service
27 Jul 2020	Issuer Comment	AstraZeneca PLC: Credit metrics improvement trajectory remains on track following new collaboration with Daiichi Sankyo	Moody's Investors Service
09 Jun 2020	Peer Snapshot	AstraZeneca PLC - March 2020 (LTM): Peer Snapshot	Moody's Investors Service
07 May 2020	Credit Opinion	AstraZeneca PLC: Update to credit analysis - metrics remain weak but deleveraging trajectory is strong	Moody's Investors Service
20 Apr 2020	Peer Snapshot	AstraZeneca PLC - December 2019 (LTM): Peer Snapshot	Moody's Investors Service
17 Feb 2020	Issuer Comment	AstraZeneca PLC: 2019 results in line with expectations and 2020 pivotal for improvement in credit metrics	Moody's Investors Service
26 Nov 2019	Peer Snapshot	AstraZeneca PLC - September 2019 (LTM): Peer Snapshot	Moody's Investors Service
24 Sep 2019	Announcement	Moody's: China's rising demand for drugs will fuel foreign pharma companies' growth into 2023	Moody's Investors Service
24 Sep 2019	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of AstraZeneca PLC	Moody's Investors Service
04 Sep 2019	Issuer Comment	AstraZeneca PLC: Farxiga’s strong results in patients with heart failure could expand usage into a new substantial market	Moody's Investors Service
29 Aug 2019	Peer Snapshot	AstraZeneca PLC - June 2019 (LTM): Peer Snapshot	Moody's Investors Service
06 Jun 2019	Peer Snapshot	AstraZeneca PLC - March 2019 (LTM): Peer Snapshot	Moody's Investors Service
16 Apr 2019	Peer Snapshot	AstraZeneca PLC - December 2018 (LTM): Peer Snapshot	Moody's Investors Service
10 Apr 2019	Credit Opinion	AstraZeneca PLC: Update to credit analysis following change of outlook to stable	Moody's Investors Service
02 Apr 2019	Rating Action	Moody's changes outlook on AstraZeneca's A3 ratings to stable; affirms ratings	Moody's Investors Service

Resultados 1 - 50 de 128

Página de 3 Next

Estudios & Calificaciones

Productos & Soluciones

Noticias & Eventos

Usuarios Registrados

¿No se ha registrado?

Moody's Integrity Hotline

Via the Internet:

By telephone from the United States:

By telephone from outside the United States: